{"id":4235,"date":"2023-04-12T15:32:53","date_gmt":"2023-04-12T14:32:53","guid":{"rendered":"https:\/\/www.simcardiotest.eu\/wordpress\/?p=4235"},"modified":"2023-05-04T14:54:02","modified_gmt":"2023-05-04T13:54:02","slug":"innovaheart-2023","status":"publish","type":"post","link":"https:\/\/www.simcardiotest.eu\/wordpress\/innovaheart-2023\/","title":{"rendered":"InnovaHeart 2023 in pictures"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

InnovaHeart is a joint European workshop on the digital heart\u00a0<\/strong>for a future where personalised cardiac care and healthcare innovations accelerate thanks to in-silicotrials & computational cardiology. InnovaHeart – edition 2023 – was organised in <\/strong>Bordeaux, France, 22 March 2023.<\/b><\/h4>

The European Commission ambitions to develop an <\/span>integrated human digital twin in Europe, as well as to create a diverse ecosystem in modelling and simulation approaches with a coherent roadmap. Cardiovascular diseases are identified as one strategic use case of interest for clinical trials supported by digital twinning technologies.<\/span><\/p>

Within this framework, a one day-workshop on the Digital Heart, initiated by the EU funded project\u00a0<\/span>SimCardioTest<\/span><\/a>, and co-organised by the EU-funded Research and Innovation Actions\u00a0<\/span>SIMCor<\/span><\/a>,\u00a0<\/span>SimInSitu<\/span><\/a>, the Coordination and Support Action\u00a0<\/span>EDITH<\/span><\/a>\u00a0and the EIT Health project\u00a0<\/span>inEurHeart<\/span><\/a> gathered the European scientific community, start-ups, SMEs and industrial companies working on the digital heart,\u00a0on the 22nd<\/sup>\u00a0of March\u00a0in\u00a0Bordeaux.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

PRESENTATIONS<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

22 MARCH<\/span><\/span> PROGRAMME AND PRESENTATIONS
<\/span><\/h3>

PDF of the presentations are available below<\/span><\/span><\/strong><\/span><\/p>


Welcome & Opening<\/span><\/strong><\/span>\u00a0<\/strong> Fran\u00e7oise Jeanson,<\/strong> R\u00e9gion Nouvelle Aquitaine<\/span><\/span>
Kyriacos Hatzaras<\/a>, European Commission – DG CNECT<\/span><\/span>
Alexis Pacquit,<\/a> EIT Health<\/span><\/span> France
The digital heart, presentation of the 5 EU projects<\/a> Maxime Sermesant<\/strong> & Mich\u00e8le Barbier<\/strong>, Inria<\/span><\/span><\/p>

IT\u2019IS Foundation Virtual Population a successful example of Virtual Cohort<\/a> – Bryn Lloyd, <\/strong>IT’IS Foundation
<\/strong><\/p>

Virtual cohort generation and multi-level validation for in-silico trials<\/a> – <\/span>Wouter Huberts<\/strong>, Technical University Eindhoven<\/span><\/span><\/span><\/p>

EDITH CSA on the digital twins,<\/a> Raphaelle Lesage<\/strong>, VPHi<\/span><\/span><\/p>

<\/span>
<\/span><\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Virtual cohorts : practical use-cases and tools<\/span><\/span><\/strong>
Chairmen Jan Br\u00fcning<\/strong>, Charit\u00e9 Universit\u00e4ts-medizin Berlin and Maxime Sermesant,<\/strong> Inria with<\/span> \u00a0Guilhem Faur\u00e9,<\/a> Microport, Ga\u00ebtan Desrues<\/a> & Josquin Harrison<\/a>, Inria and Wouter Huberts<\/a>,<\/span> Technical University Eindhoven<\/span><\/span><\/span><\/p>

\u00a0Causal AI for in-silico trials<\/a> –<\/span><\/span> Irene Balelli,<\/strong> Inria<\/span><\/span><\/p>

ASME V&V40 Working Group #3 – Patient-Specific Modelling – Tiered<\/span><\/span><\/a> \u00a0Validation\u00a0 Approac<\/a>h<\/a>,<\/span><\/span> Nils G\u00f6tzen<\/strong>, 4RealSim Services BV<\/span><\/span><\/p>

Regulatory bodies, medical devices & in-silico trials<\/a> –<\/span><\/span> C\u00e9cile Rousseau<\/strong>, <\/span><\/span>VCLS\/ Avicenna Alliance<\/span><\/span><\/p>

Roundtable. From technological readiness to evidence requirements:<\/span><\/a>
what is still needed to implement in-silico clinical trials (iSCT) in regulatory practice?<\/span>
C<\/span>hairman: Claudio Capelli<\/strong>, University College London; Jan Br\u00fcning<\/strong>, Charit\u00e9 \u2013<\/span>
Universit\u00e4tsmedizin Berlin<\/span>
Speakers:<\/span><\/strong> J\u00e9r\u00f4me Fabiano<\/strong> (EIT Health France), Raphaelle Lesage<\/strong><\/span>, (VPHi),<\/span> C\u00e9cile Rousseau<\/strong> (VCLS\/Avicenna Alliance),
<\/span><\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

VIDEO<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
AND MORE PICTURES... HERE<\/a><\/h6>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

InnovaHeart is a joint European workshop on the digital heart\u00a0for a future where personalised cardiac care and healthcare innovations accelerate thanks to in-silicotrials & computational cardiology. InnovaHeart – edition 2023 – was organised in Bordeaux, France, 22 March 2023. The European Commission ambitions to develop an integrated human digital twin in Europe, as well as […]<\/p>\n","protected":false},"author":3,"featured_media":4277,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,11],"tags":[],"class_list":["post-4235","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","category-news"],"_links":{"self":[{"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/posts\/4235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/comments?post=4235"}],"version-history":[{"count":36,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/posts\/4235\/revisions"}],"predecessor-version":[{"id":4384,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/posts\/4235\/revisions\/4384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/media\/4277"}],"wp:attachment":[{"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/media?parent=4235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/categories?post=4235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.simcardiotest.eu\/wordpress\/wp-json\/wp\/v2\/tags?post=4235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}